Listed

Molecular Partners AG: Form 20-F for the period ended Dec 31, 2024

Filed with the SEC on Mar 6, 2025 and accepted by EDGAR at Mar 6, 2025, 16:00 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2024-01-01 to 2024-12-31CHF 5.0mifrs-full:Revenue
Operating income12 months2024-01-01 to 2024-12-31−CHF 61.2mifrs-full:ProfitLossFromOperatingActivities
Income tax12 months2024-01-01 to 2024-12-31CHF 2.0kifrs-full:IncomeTaxExpenseContinuingOperations
Net income12 months2024-01-01 to 2024-12-31−CHF 54.0mifrs-full:ProfitLoss
Diluted EPS12 months2024-01-01 to 2024-12-31−CHF 1.59ifrs-full:DilutedEarningsLossPerShare
Basic EPS12 months2024-01-01 to 2024-12-31−CHF 1.59ifrs-full:BasicEarningsLossPerShare
Operating cash flow12 months2024-01-01 to 2024-12-31−CHF 59.2mifrs-full:CashFlowsFromUsedInOperatingActivities
Capital expenditure12 months2024-01-01 to 2024-12-31CHF 705.0kifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
Cash and equivalentsAt period end2024-12-31CHF 63.9mifrs-full:CashAndCashEquivalents
Current assetsAt period end2024-12-31CHF 154.3mifrs-full:CurrentAssets
Total assetsAt period end2024-12-31CHF 158.5mifrs-full:Assets
Current liabilitiesAt period end2024-12-31CHF 10.8mifrs-full:CurrentLiabilities
Total liabilitiesAt period end2024-12-31CHF 16.9mifrs-full:Liabilities
Shareholders' equityAt period end2024-12-31CHF 141.6mifrs-full:Equity
Shares outstandingAt period end2024-12-3140,363,095 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001745114-25-000009. Last ingested by Listed: Oct 29, 2026, 06:05 ET. Listed shows no prices and gives no investment advice.